Current pharmacotherapeutic approaches for the treatment of tourette syndrome

Drugs of Today

Volumn 50, Issue 2, 2014, Pages 159-179

  Egolf, A ^a   Coffey, Barbara J ^b  

^a MOUNT SINAI HOSPITAL   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Aripiprazole; Haloperidol; Tetrabenazine; Tics; Tourette syndrome

Indexed keywords

ARIPIPRAZOLE; GUANFACINE; HALOPERIDOL; PIMOZIDE; RISPERIDONE;

ATTENTION DEFICIT DISORDER; COGNITIVE THERAPY; DRUG EFFICACY; DRUG TOLERABILITY; GILLES DE LA TOURETTE SYNDROME; HUMAN; INTERVENTION STUDY; OBSESSIVE COMPULSIVE DISORDER; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; UNITED STATES;

ARIPIPRAZOLE; HALOPERIDOL; TETRABENAZINE; TICS; TOURETTE SYNDROME;

ADRENERGIC ALPHA-AGONISTS; ANTIPSYCHOTIC AGENTS; HUMANS; MENTAL DISORDERS; TOURETTE SYNDROME;

EID: 84896074282     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2014.50.2.2097801     Document Type: Review

References (158)

1. Robertson, M.M., Eapen, V., Cavanna, A.E. The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: a cross-cultural perspective. J Psychosom Res 2009, 67(6): 475-83.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition (DSM-5).
3. Robertson, M.M. The Gilles de la Tourette syndrome: the current status. Arch Dis Child Educ Pract Ed 2012, 97(5): 166-75.
4. Jankovic, J. Tourette syndrome. Phenomenology and classification of tics. Neurol Clin 1997, 15(2): 267-75. (Pubitemid 27202913)
5. Kwak, C., Dat Vuong, K., Jankovic, J. Premonitory sensory phenomenon in Tourette's syndrome. Mov Disord 2003, 18(12): 1530-3. (Pubitemid 38035379)
6. Leckman, J.F., Walker, D.E., Cohen, D.J. Premonitory urges in Tourette's syndrome. Am J Psychiatry 1993, 150(1): 98-102. (Pubitemid 23059171)
7. Scahill, L.D., Leckman, J.F., Marek, K.L. Sensory phenomena in Tourette's syndrome. Adv Neurol 1995, 65: 273-80.
8. Leckman, J.F., Bloch, M.H., Scahill, L., King, R.A. Tourette syndrome: the self under siege. J Child Neurol 2006, 21(8): 642-9. (Pubitemid 44295122)
9. Bloch, M.H., Leckman, J.F. Clinical course of Tourette syndrome. J Psychosom Res 2009, 67(6): 497-501.
10. Bloch, M.H., Peterson, B.S., Scahill, L., Otka, J., Katsovich, L., Zhang, H., Leckman, J.F. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Arch Pediatr Adolesc Med 2006, 160(1): 65-9. (Pubitemid 43042137)
11. Hassan, N., Cavanna, A.E. The prognosis of Tourette syndrome: implications for clinical practice. Funct Neurol 2012, 27(1): 23-7.
12. Robertson, M.M. Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary. Eur Child Adolesc Psychiatry 2006, 15(1): 1-11. (Pubitemid 43333713)
13. Centers for Disease Control and Prevention. Prevalence of diagnosed Tourette syndrome in persons aged 6-17 years - United States, 2007. MMWR Morb Mortal Wkly Rep 2009, 58(21): 581-5.
14. Robertson, M.M., Eapen, V. Pharmacologic controversy of CNS stimulants in Gilles de la Tourette's syndrome. Clin Neuropharmacol 1992, 15(5): 408-25.
15. Robertson, M.M. Tourette syndrome, associated conditions and the complexities of treatment. Brain 2000, 123(3): 425-62. (Pubitemid 30099531)
16. Leckman, J.F., Riddle, M.A., Hardin, M.T., Ort, S.I., Swartz, K.L., Stevenson, J., Cohen, D.J. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989, 28(4): 566-73. (Pubitemid 19196295)
17. Scharf, J.M., Yu, D., Mathews, C.A. et al. Genome-wide association study of Tourette's syndrome. Mol Psychiatry 2013, 18(6): 721-8.
18. Kurlan, R., Eapen, V., Stern, J., McDermott, M.P., Robertson, M. M. Bilineal transmission in Tourette's syndrome families. Neurology 1994, 44(12): 2336-42. (Pubitemid 24382733)
19. Singer, H.S., Minzer, K. Neurobiology of Tourette's syndrome: concepts of neuroanatomic localization and neurochemical abnormalities. Brain Dev 2003, 25 Suppl 1: S70-84. (Pubitemid 39658654)
20. Bockner, S. Gilles de la Tourette's disease. J Ment Sci 1959, 105: 1078-81.
21. Felling, R.J., Singer, H.S. Neurobiology of tourette syndrome: current status and need for further investigation. J Neurosci 2011, 31(35): 42387-95.
22. Kalanithi, P.S., Zheng, W., Kataoka, Y. et al. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci U S A 2005, 102(37): 13307-12. (Pubitemid 41325019)
23. Azrin, N.H., Peterson, A.L. Treatment of Tourette syndrome by habit reversal: a waiting-list control group comparison. Behav Ther 1990, 21(3): 305-18. (Pubitemid 20292797)
24. Deckersbach, T., Rauch, S., Buhlmann, U., Wilhelm, S. Habit reversal versus supportive psychotherapy in Tourette's disorder: a randomized controlled trial and predictors of treatment response. Behav Res Ther 2006, 44(8): 1079-90. (Pubitemid 43949248)
25. O'Connor, K.P., Brault, M., Robillard, S., Loiselle, J., Borgeat, F., Stip, E. Evaluation of a cognitive-behavioural program for the management of chronic tic and habit disorders. Behav Res Ther 2001, 39(6): 667-81. (Pubitemid 32280207)
26. Verdellen, C.W., Keijsers, G.P., Cath, D.C., Hoogduin, C.A. Exposure with response prevention versus habit reversal in Tourettes's syndrome: a controlled study. Behav Res Ther 2004, 42(5): 501-11. (Pubitemid 38368901)
27. Wilhelm, S., Deckersbach, T., Coffey, B.J., Bohne, A., Peterson, A.L., Baer, L. Habit reversal versus supportive psychotherapy for Tourette's disorder: a randomized controlled trial. Am J Psychiatry 2003, 160(6): 1175-7. (Pubitemid 41070980)
28. Dutta, N., Cavanna, A.E. The effectiveness of habit reversal therapy in the treatment of Tourette syndrome and other chronic tic disorders: a systematic review. Funct Neurol 2013, 28(1): 7-12.
29. Chapel, J.L., Brown, N., Jenkins, R.L. Tourette's disease: symptomatic relief with haloperidol. Am J Psychiatry 1964, 121: 608-10.
30. Craven, E.M. Gilles de la Tourette syndrome treated with haloperidol. JAMA 1969, 210(1): 134.
31. Lucas, A.R. Gilles de la Tourette's disease in children: treatment with haloperidol. Am J Psychiatry 1967, 124(2): 243-5.
32. Shapiro, A.K., Shapiro, E. Treatment of Gilles de la Tourette's syndrome with haloperidol. Br J Psychiatry 1968, 114(508): 345-50.
33. Sallee, F.R., Nesbitt, L., Jackson, C., Sine, L., Sethuraman, G. Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder. Am J Psychiatry 1997, 154(8): 1057-62. (Pubitemid 27328819)
34. Shapiro, E., Shapiro, A.K., Fulop, G., Flubbard, M., Mandeli, J., Nordlie, J., Phillips, R.A. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 1989, 46(8): 722-30. (Pubitemid 19198099)
35. Borison, R.L., Ang, L., Hamilton, W.J., Diamond, B.I., Davis, J.M. Treatment approaches in Gilles de la Tourette syndrome. Brain Res Bull 1983, 11(2): 205-8. (Pubitemid 13016843)
36. Ross, M.S., Moldofsky, H. A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome. Am J Psychiatry 1978, 135(5): 585-7. (Pubitemid 8329032)
37. Bruggeman, R., van der Linden, C., Buitelaar, J.K., Gericke, G.S., Hawkridge, S.M., Temlett, J.A. Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study. J Clin Psychiatry 2001, 62(1): 50-6. (Pubitemid 32154319)
38. Gilbert, D.L., Batterson, J.R., Sethuraman, G., Sallee, F.R. Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial. J Am Acad Child Adolesc Psychiatry 2004, 43(2): 206-14.
39. Pringsheim, T., Marras, C. Pimozide for tics in Tourette's syndrome. Cochrane Database Syst Rev 2009(2): CD006996.
40. Gulisano, M., Cali, P.V., Cavanna, A.E., Eddy, C., Rickards, H., Rizzo, R. Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome. Neurol Sci 2011, 32(6): 1213-7.
41. Wijemanne, S., Wu, L.J., Jankovic, J. Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome. Mov Disord 2013, 29(1): 126-30.
42. Dion, Y., Annable, L., Sandor, P, Chouinard, G. Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial. J Clin Psychopharmacol 2002, 22(1): 31-9. (Pubitemid 34101290)
43. Gaffney, G.R., Perry, P.J., Lund, B.C., Bever-Stille, K.A., Arndt, S., Kuperman, S. Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 2002, 41(3): 330-6. (Pubitemid 38338155)
44. Scahill, L., Leckman, J.F., Schultz, R.T., Katsovich, L., Peterson, B.S. A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 2003, 60(7): 1130-5. (Pubitemid 36418773)
45. Bruun, R.D., Budman, C.L. Risperidone as a treatment for Tourette's syndrome. J Clin Psychiatry 1996, 57(1): 29-31. (Pubitemid 26030525)
46. Kim, B.N., Lee, C.B., Hwang, J.W., Shin, M.S., Cho, S.C. Effectiveness and safety of risperidone for children and adolescents with chronic tic or Tourette disorders in Korea. J Child Adolesc Psychopharmacol 2005, 15(2): 318-24.
47. Lombroso, P.J., Scahill, L., King, R.A. et al. Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report. J Am Acad Child Adolesc Psychiatry 1995, 34(9): 1147-52.
48. Robertson, M.M., Scull, D.A., Eapen, V., Trimble, M.R. Risperidone in the treatment of Tourette syndrome: a retrospective case note study. J Psychopharmacol 1996, 10(4): 317-20. (Pubitemid 27045930)
49. Sandor, P, Stephens, R.J. Risperidone treatment of aggressive behavior in children with Tourette syndrome. J Clin Psychopharmacol 2000, 20(6): 710-2.
50. Stamenkovic, M., Aschauer, H., Kasper, S. Risperidone for Tourette's syndrome. Lancet 1994, 344(8936): 1577-8.
51. Pringsheim, T., Lam, D., Ching, H., Patten, S. Metabolic and neurological complications of second-generation antipsychotic use in children: a systematic review and meta-analysis of randomized controlled trials. Drug Saf 2011, 34(8): 651-68.
52. Margolese, H.C., Annable, L., Dion, Y. Depression and dysphoria in adult and adolescent patients with Tourette's disorder treated with risperidone. J Clin Psychiatry 2002, 63(11): 1040-4. (Pubitemid 35388065)
53. Budman, C., Coffey, B.J., Shechter, R., Schrock, M., Wieland, N., Spirgel, A., Simon, E. Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts. J Child Adolesc Psychopharmacol 2008, 18(5): 509-15.
54. Cui, Y.H., Zheng, Y., Yang, Y.P., Liu, J., Li, J. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China. J Child Adolesc Psychopharmacol 2010, 20(4): 291-8.
55. Davies, L., Stern, J.S., Agrawal, N., Robertson, M.M. A case series of patients with Tourette's syndrome in the United Kingdom treated with aripiprazole. Hum Psychopharmacol 2006, 21(7): 447-53. (Pubitemid 44660184)
56. Duane, D.D. Aripiprazole in childhood and adolescence for Tourette syndrome. J Child Neurol 2006, 21(4): 358. (Pubitemid 43891140)
57. Kawohl, W., Schneider, F., Vernaleken, I., Neuner, I. Aripiprazole in the pharmacotherapy of Gilles de la Tourette syndrome in adult patients. World J Biol Psychiatry 2009, 10(4 Pt 3): 827-31.
58. Lyon, G.J., Samar, S., Jummani, R., Hirsch, S., Spirgel, A., Goldman, R., Coffey, B.J. Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study. J Child Adolesc Psychopharmacol 2009, 19(6): 623-33.
59. Masi, G., Gagliano, A., Siracusano, R. et al. Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study. J Child Adolesc Psychopharmacol 2012, 22(2): 120-5.
60. Murphy, T.K., Bengtson, M.A., Soto, O., Edge, P.J., Sajid, M.W., Shapira, N., Yang, M. Case series on the use of aripiprazole for Tourette syndrome. Int J Neuropsychopharmacol 2005, 8(3): 489-90. (Pubitemid 41002504)
61. Murphy, T.K., Mutch, P.J., Reid, J.M., Edge, P.J., Storch, E.A., Bengtson, M., Yang, M. Open label aripiprazole in the treatment of youth with tic disorders. J Child Adolesc Psychopharmacol 2009, 19(4): 441-7.
62. Neuner, I., Nordt, C., Schneider, F., Kawohl, W. Effectiveness of aripiprazole in the treatment of adult Tourette patients up to 56 months. Hum Psychopharmacol 2012, 27(4): 364-9.
63. Seo, W.S., Sung, H.M., Sea, H.S., Bai, D.S. Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder. J Child Adolesc Psychopharmacol 2008, 18(2): 197-205. (Pubitemid 351591440)
64. Wenzel, C., Kleimann, A., Bokemeyer, S., Muller-Vahl, K.R. Aripiprazole for the treatment of Tourette syndrome: a case series of 100 patients. J Clin Psychopharmacol 2012, 32(4): 548-50.
65. Yoo, H.K., Kim, J.Y., Kim, C.Y. A pilot study of aripiprazole in children and adolescents with Tourette's disorder. J Child Adolesc Psychopharmacol 2006, 16(4): 505-6. (Pubitemid 44681472)
66. Yoo, H.K., Joung, Y.S., Lee, J.S. et al. A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourette's disorder. J Clin Psychiatry 2013, 74(8): e772-80.
67. Rizzo, R., Eddy, C.M., Cali, P, Gulisano, M., Cavanna, A.E. Metabolic effects of aripiprazole and pimozide in children with Tourette syndrome. Pediatr Neurol 2012, 47(6): 419-22.
68. Caccia, S. Safety and pharmacokinetics of atypical antipsychotics in children and adolescents. Paediatr Drugs 2013, 15(3): 217-33.
69. Bengi Semerci, Z. Olanzapine in Tourette's disorder. J Am Acad Child Adolesc Psychiatry 2000, 39(2): 140.
70. Bhadrinath, B.R. Olanzapine in Tourette syndrome. Br J Psychiatry 1998, 172: 366.
71. Budman, C.L., Gayer, A., Lesser, M., Shi, Q., Bruun, R.D. An open-label study of the treatment efficacy of olanzapine for Tourette's disorder. J Clin Psychiatry 2001, 62(4): 290-4. (Pubitemid 32428769)
72. McCracken, J.T., Suddath, R., Chang, S., Thakur, S., Piacentini, J. Effectiveness and tolerability of open label olanzapine in children and adolescents with Tourette syndrome. J Child Adolesc Psychopharmacol 2008, 18(5): 501-8.
73. Stamenkovic, M., Schindler, S.D., Aschauer, H.N., De Zwaan, M., Willinger, U., Resinger, E., Kasper, S. Effective open-label treatment of Tourette's disorder with olanzapine. Int Clin Psychopharmacol 2000, 15(1): 23-8. (Pubitemid 30058135)
74. Stephens, R.J., Bassel, C., Sandor, P. Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome - a pilot study. J Child Adolesc Psychopharmacol 2004, 14(2): 255-66. (Pubitemid 38988791)
75. Onofrj, M., Paci, C., D'Andreamatteo, G., Toma, L. Olanzapine in severe Gilles de la Tourette syndrome: a 52-week double-blind cross-over study vs. low-dose pimozide. J Neurol 2000, 247(6): 443-6. (Pubitemid 30433558)
76. Maloney, A.E., Sikich, L. Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients. Neuropsychiatr Dis Treat 2010, 6: 749-66.
77. Woods, S.W., Martin, A., Spector, S.G., McGlashan, T.H. Effects of development on olanzapine-associated adverse events. J Am Acad Child Adolesc Psychiatry 2002, 41(12): 1439-46. (Pubitemid 44698520)
78. Singh, M.K., Ketter, T.A., Chang, K.D. Atypical antipsychotics for acute manic and mixed episodes in children and adolescents with bipolar disorder: efficacy and tolerability. Drugs 2010, 70(4): 433-42.
79. Parraga, H.C., Parraga, M.I., Woodward, R.L., Fenning, P.A. Quetiapine treatment of children with Tourette's syndrome: report of two cases. J Child Adolesc Psychopharmacol 2001, 11(2): 187-91. (Pubitemid 32588491)
80. Copur, M., Arpaci, B., Demir, T., Narin, H. Clinical effectiveness of quetiapine in children and adolescents with Tourette's syndrome : a retrospective case-note survey. Clin Drug Investig 2007, 27(2): 123-30. (Pubitemid 46143287)
81. Mukaddes, N.M., Abali, O. Quetiapine treatment of children and adolescents with Tourette's disorder. J Child Adolesc Psychopharmacol 2003, 13(3): 295-9. (Pubitemid 37288529)
82. Sallee, F.R., Kurlan, R., Goetz, C.G. et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry 2000, 39(3): 292-9. (Pubitemid 30127607)
83. Cornell, C.U., Lops, J.D., Figen, V., Malhotra, A.K., Kane, J.M., Manu, P. QT interval duration and dispersion in children and adolescents treated with ziprasidone. J Clin Psychiatry 2011, 72(6): 854-60.
84. DelBello, M.P., Versavel, M., Ice, K., Keller, D., Miceli, J. Tolerability of oral ziprasidone in children and adolescents with bipolar mania, schizophrenia, or schizoaffective disorder. J Child Adolesc Psychopharmacol 2008, 18(5): 491-9.
85. Findling, R.L., Cavus, I., Pappadopulos, E., Vanderburg, D.G., Schwartz, J.H., Gundapaneni, B.K., DelBello, M.P. Ziprasidone in adolescents with schizophrenia: results from a placebo-controlled efficacy and long-term open-extension study. J Child Adolesc Psychopharmacol 2013, 23(8): 531-44.
86. Du, Y.S., Li, H.F., Vance, A. et al. Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders. Aust N Z J Psychiatry 2008, 42(9): 807-13.
87. Kang, H., Zhang, Y.F., Jiao, F.Y., Guo, X.Y., Gao, X.M. [Efficacy of clonidine transdermal patch for treatment of Tourette's syndrome in children]. Zhongguo Dang Dai Er Ke Za Zhi 2009, 11(7): 537-9.
88. Hedderick, E.F., Morris, C.M., Singer, H.S. Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome. Pediatr Neurol 2009, 40(6): 420-5.
89. Leckman, J.F., Detlor, J., Harcherik, D.F., Ort, S., Shaywitz, B.A., Cohen, D.J. Short- and long-term treatment of Tourette's syndrome with clonidine: a clinical perspective. Neurology 1985, 35(3): 343-51. (Pubitemid 15100674)
90. Leckman, J.F., Hardin, M.T., Riddle, M.A., Stevenson, J., Ort, S.I., Cohen, D.J. Clonidine treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 1991, 48(4): 324-8.
91. Tourette's Syndrome Study Group. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 2002, 58(4): 527-36.
92. Gancher, S., Conant-Norville, D., Angell, R. Treatment of Tourette's syndrome with transdermal clonidine: a pilot study. J Neuropsychiatry Clin Neurosci 1990, 2(1): 66-9. (Pubitemid 20125847)
93. Goetz, C.G., Tanner, C.M., Wilson, R.S., Carroll, V.S., Como, P.G., Shannon, K.M. Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methods. Ann Neurol 1987, 21(3): 307-10. (Pubitemid 17035288)
94. Singer, H.S., Brown, J., Quaskey, S., Rosenberg, L.A., Mellits, E.D., Denckla, M.B. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Pediatrics 1995, 95(1): 74-81.
95. Cohen, D.J., Detlor, J., Young, J.G., Shaywitz, B.A. Clonidine ameliorates Gilles de la Tourette syndrome. Arch Gen Psychiatry 1980, 37(12): 1350-7. (Pubitemid 11204073)
96. Shapiro, A.K., Shapiro, E., Eisenkraft, G.J. Treatment of Gilles de la Tourette's syndrome with clonidine and neuroleptics. Arch Gen Psychiatry 1983, 40(11): 1235-40. (Pubitemid 13015020)
97. Singer, H.S., Gammon, K., Quaskey, S. Haloperidol, fluphenazine and clonidine in Tourette syndrome: controversies in treatment. Pediatr Neurosci 1985, 12(2): 71-4. (Pubitemid 16002737)
98. Scahill, L., Chappell, P.B., Kim, Y.S. et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 2001, 158(7): 1067-74. (Pubitemid 32623110)
99. Cummings, D.D., Singer, H.S., Krieger, M., Miller, T.L., Mahone, E.M. Neuropsychiatric effects of guanfacine in children with mild tourette syndrome: a pilot study. Clin Neuropharmacol 2002, 25(6): 325-32. (Pubitemid 36025273)
100. Boon-yasidhi, V., Kim, Y.S., Scahill, L. An open-label, prospective study of guanfacine in children with ADHD and tic disorders. J Med Assoc Thai 2005, 88 Suppl 8: S156-62. (Pubitemid 43175635)
101. Chappell, P.B., Riddle, M.A., Scahill, L. et al. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 1995, 34(9): 1140-6.
102. Awaad, Y. Tics in Tourette syndrome: new treatment options. J Child Neurol 1999, 14(5): 316-9. (Pubitemid 29239188)
103. Porta, M., Maggioni, G., Ottaviani, F., Schindler, A. Treatment of phonic tics in patients with Tourette's syndrome using botulinum toxin type A. Neurol Sci 2004, 24(6): 420-3. (Pubitemid 38256251)
104. Marras, C., Andrews, D., Sime, E., Lang, A.E. Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology 2001, 56(5): 605-10. (Pubitemid 32209992)
105. Salloway, S., Stewart, C.F., Israeli, L., Morales, X., Rasmussen, S., Blitzer, A., Brin, M.F. Botulinum toxin for refractory vocal tics. Mov Disord 1996, 11(6): 746-8. (Pubitemid 26381951)
106. Trimble, M.R., Whurr, R., Brookes, G., Robertson, M.M. Vocal tics in Gilles de la Tourette syndrome treated with botulinum toxin injections. Mov Disord 1998, 13(3): 617-9. (Pubitemid 28221532)
107. Vincent, D.A., Jr. Botulinum toxin in the management of laryngeal tics. J Voice 2008, 22(2): 251-6.
108. Kwak, C.H., Hanna, P.A., Jankovic, J. Botulinum toxin in the treatment of tics. Arch Neurol 2000, 57(8): 1190-3. (Pubitemid 30644667)
109. Aguirregomozcorta, M., Pagonabarraga, J., Diaz-Manera, J., Pascual-Sedano, B., Gironell, A., Kulisevsky, J. Efficacy of botulinum toxin in severe Tourette syndrome with dystonic tics involving the neck. Parkinsonism Relat Disord 2008, 14(5): 443-5.
110. Jankovic, J. Botulinum toxin in the treatment of dystonic tics. Mov Disord 1994, 9(3): 347-9. (Pubitemid 24150125)
111. Scott, B.L., Jankovic, J., Donovan, D.T. Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome. Mov Disord 1996, 11(4): 431-3. (Pubitemid 26235782)
112. Allen, A.J., Kurlan, R.M., Gilbert, D.L. et al. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology 2005, 65(12): 1941-9. (Pubitemid 43970115)
113. Ledbetter, M. Atomoxetine use associated with onset of a motor tic. J Child Adolesc Psychopharmacol 2005, 15(2): 331-3. (Pubitemid 40734113)
114. Parraga, H.C., Parraga, K.L., Harris, D.K., Campbell, T.S. Abdominal tics during atomoxetine treatment in a child with ADHD: evaluation and differential diagnosis. CNS Spectr 2008, 13(9): E1.
115. Parraga, H.C., Parraga, M.I., Harris, D.K. Tic exacerbation and precipitation during atomoxetine treatment in two children with attention-deficit hyperactivity disorder. Int J Psychiatry Med 2007, 37(4): 415-24. (Pubitemid 351468864)
116. Sears, J., Patel, N.C. Development of tics in a thirteen-year-old male following atomoxetine use. CNS Spectr 2008, 13(4): 301-3. (Pubitemid 351656251)
117. Spencer, T.J., Sallee, F.R., Gilbert, D.L. et al. Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome. J Atten Disord 2008, 11(4): 470-81.
118. Yang, C.S., Zhang, L.L., Zeng, L.N., Huang, L., Liu, Y.T. Topiramate for Tourette's syndrome in children: a meta-analysis. Pediatr Neurol 2013, 49(5): 344-50.
119. Jankovic, J., Jimenez-Shahed, J., Brown, L.W. A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. J Neurol Neurosurg Psychiatry 2010, 81(1): 70-3.
120. Kuo, S.H., Jimenez-Shahed, J. Topiramate in treatment of Tourette syndrome. Clin Neuropharmacol 2010, 33(1): 32-4.
121. Thompson, P.J., Baxendale, S.A., Duncan, J.S., Sander, J.W. Effects of topiramate on cognitive function. J Neurol Neurosurg Psychiatry 2000, 69(5): 636-41.
122. Jankovic, J., Glaze, D.G., Frost, J.D., Jr. Effect of tetrabenazine on tics and sleep of Gilles de la Tourette's syndrome. Neurology 1984, 34(5): 688-92. (Pubitemid 14143535)
123. Porta, M., Sassi, M., Cavallazzi, M., Fornari, M., Brambilla, A., Servello, D. Tourette's syndrome and role of tetrabenazine: review and personal experience. Clin Drug Investig 2008, 28(7): 443-59. (Pubitemid 351821482)
124. Kenney, C., Jankovic, J. Tetrabenazine in the treatment of hyperkinetic movement disorders. Expert Rev Neurother 2006, 6(1): 7-17.
125. Singer, H.S., Wendlandt, J., Krieger, M., Giuliano, J. Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial. Neurology 2001, 56(5): 599-604. (Pubitemid 32209991)
126. Smith-Hicks, C.L., Bridges, D.D., Paynter, N.P., Singer, H.S. A double blind randomized placebo control trial of levetiracetam in Tourette syndrome. Mov Disord 2007, 22(12): 1764-70. (Pubitemid 47597600)
127. Fernandez-Jaen, A., Fernandez-Mayoralas, D.M., Munoz-Jareno, N., Calleja-Perez, B. An open-label, prospective study of levetiracetam in children and adolescents with Tourette syndrome. Eur J Paediatr Neurol 2009, 13(6): 541-5.
128. McConville, B.J., Sanberg, P.R., Fogelson, M.H., King, J., Cirino, P., Parker, K.W., Norman, A.B. The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and freguency in Tourette's disorder. Biol Psychiatry 1992, 31(8): 832-40.
129. Sanberg, P.R., Fogelson, H.M., Manderscheid, P.Z., Parker, K.W., Norman, A.B., McConville, B.J. Nicotine gum and haloperidol in Tourette's syndrome. Lancet 1988, 1(8585): 592. (Pubitemid 18060514)
130. Silver, A.A., Shytle, R.D., Philipp, M.K., Wilkinson, B.J., McConville, B., Sanberg, P.R. Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study. J Clin Psychiatry 2001, 62(9): 707-14. (Pubitemid 32994934)
131. Dursun, S.M., Reveley, M.A. Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette's syndrome: an open study. Psychol Med 1997, 27(2): 483-7. (Pubitemid 27139981)
132. Howson, A.L., Batth, S., Ilivitsky, V., Boisjoli, A., Jaworski, M., Mahoney, C., Knott, V.J. Clinical and attentional effects of acute nicotine treatment in Tourette's syndrome. Eur Psychiatry 2004, 19(2): 102-12. (Pubitemid 38402272)
133. Silver, A.A., Shytle, R.D., Sheehan, K.H., Sheehan, D.V., Ramos, A., Sanberg, P.R. Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder. J Am Acad Child Adolesc Psychiatry 2001, 40(9): 1103-10. (Pubitemid 32803824)
134. Silver, A.A., Shytle, R.D., Sanberg, P.R. Mecamylamine in Tourette's syndrome: a two-year retrospective case study. J Child Adolesc Psychopharmacol 2000, 10(2): 59-68. (Pubitemid 30490913)
135. Sanberg, P.R., Shytle, R.D., Silver, A.A. Treatment of Tourette's syndrome with mecamylamine. Lancet 1998, 352(9129): 705-6. (Pubitemid 28398711)
136. Gabbay, V., Babb, J.S., Klein, R.G. et al. A double-blind, placebo-controlled trial of omega-3 fatty acids in Tourette's disorder. Pediatrics 2012, 129(6): e1493-500.
137. Muller-Vahl, K.R., Schneider, U., Koblenz, A., Jobges, M., Kolbe, H., Daldrup, T., Emrich, H.M. Treatment of Tourette's syndrome with delta 9-tetrahydrocannabinol (THC): a randomized crossover trial. Pharmacopsychiatry 2002, 35(2): 57-61. (Pubitemid 34293234)
138. Eggers, C., Rothenberger, A., Berghaus, U. Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride. Eur Arch Psychiatry Neurol Sci 1988, 237(4): 223-9.
139. Robertson, M.M., Schnieden, V., Lees, A.J. Management of Gilles de la Tourette syndrome using sulpiride. Clin Neuropharmacol 1990, 13(3): 229-35. (Pubitemid 20181214)
140. Ho, C.S., Chen, H.J., Chiu, N.C., Shen, E.Y., Lue, H.C. Short-term sulpiride treatment of children and adolescents with Tourette syndrome or chronic tic disorder. J Formos Med Assoc 2009, 108(10): 788-93.
141. Fountoulakis, K.N., Iacovides, A., St Kaprinis, G. Successful treatment of Tourette's disorder with amisulpride. Ann Pharmacother 2004, 38(5): 901. (Pubitemid 38509078)
142. Orth, M. Transcranial magnetic stimulation in Gilles de la Tourette syndrome. J Psychosom Res 2009, 67(6): 591-8.
143. Munchau, A., Bloem, B.R., Thilo, K.V., Trimble, M.R., Rothwell, J.C., Robertson, M.M. Repetitive transcranial magnetic stimulation for Tourette syndrome. Neurology 2002, 59(11): 1789-91. (Pubitemid 35424467)
144. Mantovani, A., Lisanby, S.H., Pieraccini, F., Ulivelli, M., Castrogiovanni, P, Rossi, S. Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS). Int J Neuropsychopharmacol 2006, 9(1): 95-100. (Pubitemid 43068339)
145. Le, K., Liu, L., Sun, M., Hu, L., Xiao, N. Transcranial magnetic stimulation at 1 Hertz improves clinical symptoms in children with Tourette syndrome for at least 6 months. J Clin Neurosci 2013, 20(2): 257-62.
146. Visser-Vandewalle, V., Temel, Y., Boon, P. et al. Chronic bilateral thalamic stimulation: a new therapeutic approach in intractable Tourette syndrome. Report of three cases. J Neurosurg 2003, 99(6): 1094-100. (Pubitemid 44717410)
147. Porta, M., Brambilla, A., Cavanna, A.E., Servello, D., Sassi, M., Rickards, H., Robertson, M.M. Thalamic deep brain stimulation for treatment-refractory Tourette syndrome: two-year outcome. Neurology 2009, 73(17): 1375-80.
148. Porta, M., Servello, D., Zanaboni, C., Anasetti, F., Menghetti, C., Sassi, M., Robertson, M.M. Deep brain stimulation for treatment of refractory Tourette syndrome: long-term followup. Acta Neurochir (Wien) 2012, 154(11): 2029-41.
149. Ackermans, L., Duits, A., van der Linden, C. et al. Double-blind clinical trial of thalamic stimulation in patients with Tourette syndrome. Brain 2011, 134(Pt 3): 832-44.
150. Mink, J.W., Walkup, J., Frey, K.A. et al. Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Disord 2006, 21(11): 1831-8. (Pubitemid 44848927)
151. Muller-Vahl, K.R., Cath, D.C., Cavanna, A.E. et al. European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation. Eur Child Adolesc Psychiatry 2011, 20(4): 209-17.
152. Neri, V., Cardona, F. Clinical pharmacology of comorbid obsessive-compulsive disorder in Tourette syndrome. Int Rev Neurobiol 2013, 112: 391-414.
153. Pringsheim, T., Steeves, T. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. Cochrane Database Syst Rev 2011(4): CD007990.
154. Bloch, M.H., Panza, K.E., Landeros-Weisenberger, A., Leckman, J.F. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. J Am Acad Child Adolesc Psychiatry 2009, 48(9): 884-93.
155. Gorman, D.A., Thompson, N., Plessen, K.J., Robertson, M.M., Leckman, J.F., Peterson, B.S. Psychosocial outcome and psychiatric comorbidity in older adolescents with Tourette syndrome: controlled study. Br J Psychiatry 2010, 197(1): 36-44.
156. Cheung, M.Y., Shahed, J., Jankovic, J. Malignant Tourette syndrome. Mov Disord 2007, 22(12): 1743-50. (Pubitemid 47597597)
157. Cavanna, A.E., Eddy, C.M., Mitchell, R. et al. An approach to deep brain stimulation for severe treatment-refractory Tourette syndrome: the UK perspective. Br J Neurosurg 2011, 25(1): 38-44.
158. Shapiro, A.K., Shapiro, E. Controlled study of pimozide vs. placebo in Tourette's syndrome. J Am Acad Child Psychiatry 1984, 23(2): 161-73. (Pubitemid 14066109)